Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Road Walker who wrote (13347)	2/8/2010 4:45:22 PM
From: TimF	Read Replies (1) \| Respond to of 42652

They would have to raise prices to other governments If they could do that now, they would. To the extent the governments have monopsony buying, or even in a few cases explicitly price controls, or at least heavy political pressure and control on prices, the drug companies have little pricing power with other countries. They could try a take it or leave it approach, but even that might not work, as if other countries are cut off they may set up a compulsory licensing system and give the rights to their local companies to produce drugs who's patent is held by American companies (or potentially companies from other countries that want to offer the same "take it or leave it" price to the governments) the markets have organized themselves in a certain way. No they haven't. Governments have organized them in certain ways, that's a very different thing.